Polynucleotides encoding low density lipoprotein receptor
Abstract:
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotide molecules encoding low density lipoprotein receptor comprising at least one mutation (e.g., an LDLR signally enhancing mutation).
Public/Granted literature
Information query
Patent Agency Ranking
0/0